Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14367126 | 0.83 | MMP2 (0.46) | MMP2ANPEP | |
| SCHEMBL21682443 | 0.81 | ATM (0.42) | ATMMMP2ANPEP | |
| SCHEMBL6917231 | 0.81 | ATM (0.42) | ATMMMP2ANPEP | |
| SCHEMBL6857780 | 0.81 | MMP2 (0.35) | ATMMMP2ANPEP | |
| SCHEMBL1251163 | 0.81 | ATM (0.42) | ATMMMP2ANPEP | |
| SCHEMBL1251167 | 0.81 | ATM (0.42) | ATMMMP2ANPEP | |
| SCHEMBL1251161 | 0.81 | ATM (0.42) | ATMMMP2ANPEP | |
| SCHEMBL12362348 | 0.78 | ATM (0.36) | ATMMMP2ANPEP | |
| SCHEMBL688826 | 0.78 | ATM (0.36) | ATMMMP2ANPEP | |
| SCHEMBL13684382 | 0.78 | ATM (0.36) | ATMMMP2ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7091363-B2 | Compounds for the preparation of carbapenem-type antibacterial agents | SANKYO COMPANY, LIMITED (JP) | 2006-08-15 | — | — | US | disclosed |
| US-7034150-B2 | Processes for the preparation of carbapenem-type antibacterial agents | SANKYO COMPANY, LIMITED (JP) | 2006-04-25 | — | — | US | disclosed |
| US-20060009508-A1 | Compounds for the preparation of carbapenem-type antibacterial agents | SANKYO COMPANY, LIMITED (JP) | 2006-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060009508-A1 | Compounds for the preparation of carbapenem-type antibacterial agents | TET1, MRPL21, RPS6KA1 | ATM 1693/4885MMP2 2063/4885ANPEP 1285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.